𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

✍ Scribed by Per E. Lønning; Svein I. Helle; Dag C. Johannessen; Dagfinn Ekse; Herman Adlercreutz

Publisher
Springer US
Year
1996
Tongue
English
Weight
575 KB
Volume
39
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma levels of the atherogenic amino a
Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen
✍ G. Anker; P. E. Lonning; P. M. Ueland; H. Refsum; E. A. Lien 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 488 KB 👁 2 views

Long-term treatment of breast-cancer patients with the anti-oestrogen tamoxifen has been found to be associated with reduced cardiovascular mortality. Plasma homocysteine is an independent risk factor for atherosclerotic disease, and its level is determined by folate and cobalamin status, and possib

The association of plasma androgen level
The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women
✍ Kim N. Danforth; A. Heather Eliassen; Shelley S. Tworoger; Stacey A. Missmer; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 143 KB 👁 2 views

## Abstract Although androgens may play an etiologic role in breast, ovarian and endometrial cancers, little is known about factors that influence circulating androgen levels. We conducted a cross‐sectional analysis among 646 postmenopausal women in the Nurses' Health Study to examine associations

The distribution of oestradiol in plasma
The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: Relationships with metabolic clearance rates of oestradiol
✍ M. J. Reed; P. A. Beranek; R. W. Cheng; M. W. Ghilchik; V. H. T. James 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 429 KB 👁 2 views

## Abstract The distribution of oestradiol in plasma from post‐menopausal women with or without breast cancer has been measured and related to the metabolic clearance rates of oestradiol (MCR‐E2). All measurements were carried out preoperatively. No difference in the free fraction of oestradiol was